Denis Dufrane
Vorstandsvorsitzender bei Novadip Biosciences SA
Aktive Positionen von Denis Dufrane
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Novadip Biosciences SA
Novadip Biosciences SA BiotechnologyHealth Technology Novadip Biosciences SA operates as a advanced biopharmaceutical company that develops cell-based therapies to treat patients with critical size bone defects and severe bone diseases. Its proprietary product, Creost, is a natural scaffold-free and tridimensional bone structure, which reconstructs large bone defects without the need of any biomaterial. The firm is a osteogenic living implant with a mineralization similar to a real bone. Its Creost is an autologous cell based-therapy product obtained from Adipose-derived Mesenchymal Stem Cells (AMSCs) which promotes (i) a perfect engraftment without any scaffold and (ii) a tissue remodeling with all native bone properties. Novadip Biosciences was founded by Jean-Fran?ois Pollet and Denis Dufrane in 2013 and is headquartered in Louvain-la-Neuve, Belgium. | Direktor/Vorstandsmitglied | - | - |
Vorstandsvorsitzender | 01.01.2013 | - | |
Technik-/Wissenschafts-/F&E-Leiter | 01.01.2013 | - | |
Gründer | 01.01.2013 | - | |
Superior Health Council | Corporate Officer/Principal | - | - |
Karriereverlauf von Denis Dufrane
Ehemalige bekannte Positionen von Denis Dufrane
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Cliniques Universitaires Saint-Luc
Cliniques Universitaires Saint-Luc Hospital/Nursing ManagementHealth Services Cliniques Universitaires Saint-Luc operates as a hospital which provides reference care and treats serious, rare or complex diseases of patients. The company was founded on August 23, 1976 and is headquartered in Brussels, Belgium. | Corporate Officer/Principal | 01.01.2002 | 01.08.2015 |
Statistik
International
Belgien | 4 |
Operativ
Corporate Officer/Principal | 2 |
Director/Board Member | 1 |
Chief Executive Officer | 1 |
Sektoral
Health Technology | 2 |
Health Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 3 |
---|---|
Novadip Biosciences SA
Novadip Biosciences SA BiotechnologyHealth Technology Novadip Biosciences SA operates as a advanced biopharmaceutical company that develops cell-based therapies to treat patients with critical size bone defects and severe bone diseases. Its proprietary product, Creost, is a natural scaffold-free and tridimensional bone structure, which reconstructs large bone defects without the need of any biomaterial. The firm is a osteogenic living implant with a mineralization similar to a real bone. Its Creost is an autologous cell based-therapy product obtained from Adipose-derived Mesenchymal Stem Cells (AMSCs) which promotes (i) a perfect engraftment without any scaffold and (ii) a tissue remodeling with all native bone properties. Novadip Biosciences was founded by Jean-Fran?ois Pollet and Denis Dufrane in 2013 and is headquartered in Louvain-la-Neuve, Belgium. | Health Technology |
Cliniques Universitaires Saint-Luc
Cliniques Universitaires Saint-Luc Hospital/Nursing ManagementHealth Services Cliniques Universitaires Saint-Luc operates as a hospital which provides reference care and treats serious, rare or complex diseases of patients. The company was founded on August 23, 1976 and is headquartered in Brussels, Belgium. | Health Services |
Superior Health Council |
- Börse
- Insiders
- Denis Dufrane
- Erfahrung